Effect of Robot-assisted Training on Foot Drop in Multiple Sclerosis

Sponsor
US Department of Veterans Affairs (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT00872053
Collaborator
(none)
18
1
2
11
1.6

Study Details

Study Description

Brief Summary

The primary aim of this study is to:
  1. Collect pilot data on the effect of task-specific lower extremity training using the Anklebot on subjects with Multiple Sclerosis (MS) and who have foot drop;

  2. Collect pilot data on the use of combination therapy on improving gait in subjects with MS. This therapy will use both Anklebot training and robot-assisted gait training.

Hypothesis: Both trainings will result in improved walking performance, but the combination therapy will result in greater gains than ankle training alone.

Condition or Disease Intervention/Treatment Phase
  • Device: Anklebot
  • Device: Lokomat
Phase 1/Phase 2

Study Design

Study Type:
Interventional
Anticipated Enrollment :
18 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effect of Robot-assisted Training on Foot Drop in Multiple Sclerosis
Study Start Date :
Feb 1, 2009
Actual Primary Completion Date :
Dec 1, 2009
Actual Study Completion Date :
Jan 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Experimental: Arm 1

Focused Ankle Training

Device: Anklebot
The Anklebot is a robotic device that is worn via a leather boot and knee brace (Fig.1). As the participant goes through a series of ankle-training "games," the Anklebot can assist ankle movement throughout 3 planes.

Experimental: Arm 2

Combination Therapy

Device: Anklebot
The Anklebot is a robotic device that is worn via a leather boot and knee brace (Fig.1). As the participant goes through a series of ankle-training "games," the Anklebot can assist ankle movement throughout 3 planes.

Device: Lokomat
The Lokomat is a motor driven exoskeleton device that employs a body weight support suspension system and treadmill. Attached to the lower limbs, the Lokomat moves the subject's legs over a treadmill through position controlled trajectories that mimic normal human gait patterns.

Outcome Measures

Primary Outcome Measures

  1. Ankle accuracy and stiffness [At inclusion, after 8 sessions, after 16 sessions]

Secondary Outcome Measures

  1. Gait assessments (e.g., 6-Minute Walk, Timed 25-Foot Walk) [At inclusion, after every 4 sessions]

  2. Functional assessments (EDSS, MS Functional Composite) [At inclusion, after 8 sessions, after 16 sessions]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Clinical diagnosis of MS by McDonald criteria (McDonald, Compston et al. 2001). EDSS level between 3.5-5.5, who report ambulation problems.

  • Presence of unilateral foot drop that is clinically apparent to the PI or PI designate.

  • Must be able to ambulate 25 feet without an assisting device.

Exclusion Criteria:
  • Cardiovascular: recent MI < 4 wk, uncontrolled HTN >190/110 mmHg.

  • History of uncontrolled diabetes.

  • Symptoms of orthostasis when standing up.

  • Circulatory problems, history of vascular claudication or pitting edema.

  • Unable to fully understand instructions in order to use the equipment or the process of the study.

  • Body weight over 150 kg.

  • Lower extremity injuries that limit range of motion or function.

  • Joint problems (hip or leg) that limit range of motion or cause pain with movement despite treatment.

  • Unstable fractures.

  • Pressure sores with any skin breakdown in areas in contact with the body harness or Lokomat apparatus.

  • Chronic and ongoing alcohol or drug abuse.

  • Pre-morbid, ongoing depression or psychosis.

  • Ongoing physical therapy.

  • Pregnancy (self-reported)

  • PI's determination of inability to complete the test protocol

Contacts and Locations

Locations

Site City State Country Postal Code
1 Providence VA Medical Center Providence Rhode Island United States 02908-4799

Sponsors and Collaborators

  • US Department of Veterans Affairs

Investigators

  • Principal Investigator: Albert Lo, MD PhD, Providence VA Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
US Department of Veterans Affairs
ClinicalTrials.gov Identifier:
NCT00872053
Other Study ID Numbers:
  • B4125K-1
First Posted:
Mar 31, 2009
Last Update Posted:
Sep 20, 2013
Last Verified:
Sep 1, 2013
Keywords provided by US Department of Veterans Affairs
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 20, 2013